Sumatriptan
Product Images NDC 67296-1224

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sumatriptan (NDC 67296-1224). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1. Estimated Probability Of Achieving Initial Headache Response Within 4 Hours Of Treatment In Pooled Trials 1, 2, And 3a (Sumatriptan Fig1)

Figure 1. Estimated Probability Of Achieving Initial Headache Response Within 4 Hours Of Treatment In Pooled Trials 1, 2, And 3a (Sumatriptan Fig1)
A line graph showing the estimated probability of response over time in minutes from the initial dose for Sumatriptan at various doses (25 mg, 50 mg, 100 mg) compared to placebo. The x-axis represents time from 0 to 240 minutes, and the y-axis represents the estimated probability of response from 0% to 100%. Each dose curve shows an increasing probability of response over time, with higher doses consistently showing greater response than placebo.*
FDA Label Image

Figure 2. The Estimated Probability Of Patients Taking A Second Dose Of Sumatriptan Tablets Or Other Medication To Treat Migraine Over The 24 Hours Following The Initial Dose Of Study Treatment In Poo (Sumatriptan Fig2)

Figure 2. The Estimated Probability Of Patients Taking A Second Dose Of Sumatriptan Tablets Or Other Medication To Treat Migraine Over The 24 Hours Following The Initial Dose Of Study Treatment In Poo (Sumatriptan Fig2)
A line graph showing the estimated probability of headache remission or relief over 24 hours after initial dosing for Sumatriptan at 25 mg, 50 mg, and 100 mg doses compared to placebo. The x-axis represents time in hours, and the y-axis shows the percentage probability ranging from 0% to 100%. Each dose corresponds to a distinct curve depicting its effect over time.*
FDA Label Image

Package Label-principal Display Panel (25 mg (36 Tablets Bottle))

Package Label-principal Display Panel (25 mg (36 Tablets Bottle))
Sumatriptan Tablets USP 25 mg label showing packaging details, including dosage and storage instructions. The label indicates 36 tablets per package, with distribution by Aurobindo Pharma USA, Inc., and manufacturing origin in India. Additional information includes NDC code and barcode, with directions to swallow tablets whole with water.*
FDA Label Image

Package Label-principal Display Panel (25 mg Blister Carton (9 Unit-dose))

Package Label-principal Display Panel (25 mg Blister Carton (9 Unit-dose))
Box packaging label for Sumatriptan Tablets, USP 25 mg, showing 9 unit-dose tablets. The label includes the product name, strength, NDC 65862-146-36, and instructions for use and storage. The labeler Aurobindo Pharma USA, Inc. is noted, with distribution details and child-resistant package warnings.*
FDA Label Image

Package Label-principal Display Panel (50 mg (36 Tablets Bottle))

Package Label-principal Display Panel (50 mg (36 Tablets Bottle))
Sumatriptan Tablets USP 50 mg label showing packaging for 36 tablets by Aurobindo Pharma USA, Inc. The label includes dosage information, storage instructions, and distributor address. The label is marked Rx only and notes tablets should be swallowed whole with water.*
FDA Label Image

Package Label-principal Display Panel (50 mg Blister Carton (9 Unit-dose))

Package Label-principal Display Panel (50 mg Blister Carton (9 Unit-dose))
Packaging label for Sumatriptan Tablets, USP 50 mg by RedPharm Drug, showing 9 unit-dose tablets. The label includes dosage strength, NDC 65862-147-36, manufacturer name Aurobindo Pharma USA, and usage instructions. The carton features barcodes, storage conditions, and pictorial directions for tablet removal from blister packaging.*
FDA Label Image

Package Label-principal Display Panel (100 mg (36 Tablets Bottle))

Package Label-principal Display Panel (100 mg (36 Tablets Bottle))
Label for Sumatriptan Tablets USP 100 mg, containing 36 tablets. The label includes NDC 65862-148-59 and states each tablet contains 140 mg sumatriptan succinate USP equivalent to 100 mg sumatriptan. Distributed by Aurobindo Pharma USA, Inc., made in India. Storage instructions and usage notes are also present.*
FDA Label Image

Package Label-principal Display Panel (100 mg Blister Carton (9 Unit-dose))

Package Label-principal Display Panel (100 mg Blister Carton (9 Unit-dose))
Packaging label for Sumatriptan Tablets, USP 100 mg, Rx only. The label shows the brand name Sumatriptan, the strength 100 mg, and mentions each tablet contains 140 mg sumatriptan succinate USP equivalent to 100 mg of sumatriptan. The package contains 9 unit-dose tablets and includes labeling from Aurobindo Pharma USA, Inc. with storage instructions and usage precautions.*
FDA Label Image

Chemical Structure (Sumatriptan Str)

Chemical Structure (Sumatriptan Str)
Chemical structure of Sumatriptan, showing its indole core with side chains including sulfonamide and dimethylaminoethyl groups, as well as carboxylic acid moieties.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.